ntegral BioSystems, located in Bedford, Massachusetts, is a leading contract research organization that has been serving the bio-pharmaceutical industry since 2011. With a state-of-the-art facility spanning 10,000 square feet, we specialize in the development of complex formulations and dosage forms for a wide range of applications including ophthalmics, dermals, injectables, otic, pulmonary, intranasal, and rectal dose forms. Our expertise extends to sustained release drug development, featuring technologies like injectable microspheres, liposomes, hydrogels, nano-complexes, and micro/nanocrystals. Our Services: Formulation Development: Creating complex formulations for many molecules, including small molecules, proteins, peptides, and nucleic acids. Analytical Method Development: Ensuring precise and reliable analysis for all development stages. Scale-Up/Technology Transfer: Efficiently transitioning from lab-scale to production. Licensable Technologies: Offering innovative, patent-protected delivery systems for enhanced drug delivery. Why Choose Integral BioSystems? Expertise: Our team brings together years of experience in drug formulation and development, backed by a significant track record of success. Innovation: We are dedicated to advancing drug delivery through cutting-edge research and development. Credibility: Recognized in the industry for our professionalism and the high quality of our work, establishing us as a trusted partner in pharmaceutical development. Integral BioSystems is recognized for its profound impact on the pharmaceutical industry, evidenced by our significant track record and credibility. Our mission is to facilitate the seamless transition of research concepts to clinic-ready products, overcoming challenges in drug delivery and formulation development. We are committed to innovation, quality, and client satisfaction, underpinned by a team of highly skilled professionals. Specialties Complex drug formulation development, microspheres, drug delivery experts, ophthalmics, licensable 505b2 patented drug delivery systems, Generics/Development/Q3 Characterization, Corneal Permeability Testing, Nanocrystals Development, Protein/Peptide/RNAi/DNA Delivery, and Physicochemical Characterization